Skip to content

Efficacy and Safety of Focused Ultrasound Versus Radiofrequency in the Treatment of Improving Facial Laxity in the Lower

Efficacy and Safety of Focused Ultrasound Versus Radiofrequency in the Treatment of Improving Facial Laxity in the Lower

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101549
Enrollment
Unknown
Registered
2025-04-25
Start date
2025-05-15
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Laxity

Interventions

Group A:Focused ultrasound therapy once. Treatment parameters: Ultrasonic knife handle M4.5/M3.0, energy of 6.63w, length of 25mm, spacing of 1.5mm
Ultrasonic cannon handle D4.5/D3.0, energy of 6.63w, frequency 10Hz.
Group B:Four bipolar radiofrequency treatments with one-week intervals. Treatment parameters: Forma M(MiniFX) handpiece with a treatment unit of 4 cm×4 cm, energy of 21-25 J/cm2, critical temperature
Forma handpiece with a set energy of 45-53 J/cm2, critical temperature of 39.5-4?.

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 35-65 years with mild to moderate facial soft tissue laxity and a desire for rejuvenation. 2. BMI between 18-29kg/m^2. 3. Those who have good adherence and be able to participate in regular follow-up visits.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Patients with severe organic and systemic diseases, malignant tumor, immunodeficiency diseases and mental diseases; 3. Those who have undergone comprehensive facial plastic surgery or other cosmetic procedures( such as phototherapy, radiofrequency, botulinum toxin injection, hyaluronic acid fillers, etc.)within the past 6 months; 4. Patients with acute or progressive skin diseases that affect the whole body or face; 5. Patients with active facial infections or open wounds; 6. Patients with metal implants such as pacemakers in their bodies; 7. Investigators who are participating in other clinical trials; 8. Those who, in the opinion of the investigator, are not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Facial Laxity Rating Scale;

Secondary

MeasureTime frame
Global Aesthetic Improvement;Skin thickness;Subcutaneous fat thickness;Skin echo intensity;Skin elasticity;Skin hydration;Transepidermal water loss;Erythema index;

Countries

China

Contacts

Public ContactFenglin Zhuo

Beijing Friendship Hospital, Capital Medical University

18541261932@163.com+86 159 1089 5068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026